Short answer. Appendix A of the Oct 28, 2026 policy is BPC-157, epitalon, KPV, MOTS-c, semax, and TB-500 [2]. Sermorelin is not on it. The announcement did not change sermorelin's category. As of Oct 29, 2026.

A different peptide

Sermorelin is a synthetic peptide related to growth hormone-releasing hormone. That description is on the sermorelin page. It is not BPC-157, and it is not a silent substitute for one of the six.

The six were the peptides in this enforcement policy because they are not components of an FDA-approved drug and are not on the 503A bulks list, which is why HHS wrote an interim policy while rulemaking continues [2]. Sermorelin has its own regulatory history, including older approved products that left the market. Compounded sermorelin is still not FDA-approved. FDA does not review compounded medicines for safety, effectiveness, or quality before marketing. That line was true on Oct 27 and it is true after this notice [1].

Do not let a headline about six peptides rewrite a sermorelin ad, a sermorelin consent, or a sermorelin price. Confirm sermorelin details on the live page the day you read them.

What Sommar does and does not offer

A licensed clinician can consider compounded sermorelin when it is appropriate. That is a prescription decision. Sommar Club does not prescribe or sell BPC-157, TB-500, MOTS-c, epitalon, semax, or KPV. The Journal pages about those six are education.

If a post says "sermorelin and the new peptide law," it is mixing two files. There is no new sermorelin statute in the Oct 28 notice [1][2].

FAQ

Did HHS approve sermorelin on Oct 28? No. Sermorelin is not in the policy, and the policy does not approve the peptides it does name [1][2].

Is ipamorelin included because people compare it with sermorelin? No. Ipamorelin is not in Appendix A either [2].

Sources

1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

2. HHS policy, Appendix A. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Compounded sermorelin is not FDA-approved. A clinician decides. Education on the other six is not an offer to prescribe them. As of Oct 29, 2026.